Exposure to atmospheric particulate matter (PM) has been associated with heightened risks of lung cancer, cardiovascular and respiratory diseases. PM exposure also affects the immune system, leading to an increased susceptibility to infections, exacerbating pre-existent inflammatory and allergic lung diseases. Atmospheric PM can primarily impact human health through the generation of reactive oxygen species (ROS) that subsequently induce or exacerbate inflammation.
View Article and Find Full Text PDFAirborne pollen allergens-a relevant component of bioaerosols and, therefore, of airborne particulate matter-are considered an important metric in air quality assessments. Although the measurement of airborne pollen allergen concentrations in outdoor environments (namely, in urban areas) has been recognized as a key environmental health indicator, no such obligation exists for indoor environments (dwellings or occupational settings). However, people spend most of their daily time (80-90%) indoors, where the majority of their exposure to air pollution, including pollen allergens, occurs.
View Article and Find Full Text PDFThe impact of inhalable fine particulate matter (PM, aerodynamic diameter <2.5 μm) on public health is of great concern worldwide. Knowledge on their harmful effects are mainly due to studies carried out with whole air particles, with the contribution of their different fractions remaining largely unknown.
View Article and Find Full Text PDF